DIN 02229418 — NAROPIN 10 MG
NAROPIN is a solution of Ropivacaine marketed by ASPEN PHARMACARE CANADA INC.. The full Ropivacaine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02229418
- Brand name
- NAROPIN
- Active ingredient
- Ropivacaine
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- EPIDURAL
- Manufacturer
- ASPEN PHARMACARE CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Local anesthetic (amide type)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ropivacaine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02229411 | NAROPIN | 2 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | MARKETED |
| 02229415 | NAROPIN | 5 MG | SOLUTION | ASPEN PHARMACARE CANADA INC. | MARKETED |
| 02439409 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 10 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02439379 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 2 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02439387 | ROPIVACAINE HYDROCHLORIDE INJECTION, USP | 5 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |